Click image to zoom

Hong Kong Resumes Biontech Vaccination Programme

An 84-year old resident receives his second Pfizer-Biontech dose of vaccine at the Hiu Kwong vaccination center in Hong Kong, China, on 7 Apr 2021. Originally scheduled for April 1st, his shot was rebooked to April 7th, after Hong Kong said they found packaging issues with the batches used for the first shot. After a suspension due to concerns around the packaging of batches of Pfizer-Biontech vaccines, Hong Kong resumed its vaccination program for this jab. The bookings for first and second dose far outpaced the Chinese Coronavac vaccine, beset by concerns over its safety after several deaths with cardiovascular issues happened in patients days or weeks after the jabs. The authorities have said the deaths were not linked to the Chinese vaccines. Uptake for the Pfizer-Biontech vaccine has been higher at about 15,000 bookings per day. (Photo by Marc Fernandes/NurPhoto)

Photo Details

Related Keywords